Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,615 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03449264Recruiting
Database study for people with certain new cancers
This study builds a clinical and biological database for people newly diagnosed with certain cancers. It may help doctors better understand cancer patterns and improve future care, and it involves agreeing to extra blood samples.
MontpellierAges 18 years+ - NCT04221464Recruiting
Building a database for peritoneal cancer care
This study collects medical information and small tissue or fluid samples from people with peritoneal (abdominal lining) cancer. It aims to better understand the disease and improve future care plans.
MontpellierAges 18 years+ - NCT04224064Recruiting
Blood test to help diagnose and predict liposarcoma
This study looks for a new blood test marker that may help doctors diagnose liposarcoma and estimate how it may behave over time. You may be asked for a blood sample and consent, and the study may follow you to see how well the test works.
MontpellierAges 18 years+ - NCT04282122Recruiting
Personalized radiation plan for older women with early breast cancer
This trial uses individual measures of how sensitive your body’s tissues are to radiation to guide after-surgery breast radiation treatment. It aims to keep treatment safe and effective while tailoring the plan to each person.
Montpellier, OccAges 65 years+ - NCT04823923Recruiting
How kidney failure affects drug levels in metastatic kidney cancer
This study looks at how chronic kidney failure changes the amount of certain cancer medicines in the blood. It involves people with metastatic clear cell kidney cancer who take pazopanib or cabozantinib, and compares drug levels in different kidney function groups.
MarseilleAges 18 years+ - NCT06306625Recruiting
Remote conditioning after out-of-hospital cardiac arrest
This trial tests a treatment that uses a blood pressure cuff on your arms to try to protect your brain and organs after your heart stopped outside the hospital. You will be in the intensive care unit, and the study will check if this simple 'remote conditioning' can improve recovery.
BronAges 18–80 - NCT07413939RecruitingPhase 2/Phase 3
Study of RO7771950 vs tucatinib for HER2-positive breast cancer
This trial tests a new drug, RO7771950, against another drug called tucatinib. Both are given with standard chemotherapy to see which works better for advanced breast cancer that is HER2-positive. People with brain metastases may join.
Huntsville, AlabamaAges 18 years+ - NCT07409272RecruitingPhase 3
Study of setidegrasib with chemo for pancreatic cancer
This trial tests a new drug called setidegrasib, given with two types of chemotherapy (mFOLFIRINOX or NALIRIFOX), for people whose pancreatic cancer has spread and has a specific genetic change called KRAS G12D. The goal is to see if adding setidegrasib helps control the cancer better than chemo alone.
Tucson, ArizonaAges 18 years+ - NCT07410949Recruiting
Acupressure education after birth and breastfeeding success
This study tests whether teaching new mothers acupressure can improve their breastfeeding experience. If you have had a healthy single baby, plan to breastfeed, and are within the first two days after delivery, you may be able to join.
Niğde, MerkezAges 18–45 - NCT07414758RecruitingPhase 3
Golidocitinib vs placebo for PTCL maintenance after first chemo
This trial tests whether a daily pill called golidocitinib can keep your PTCL from coming back after you've had a good response to your first chemotherapy. The study compares the drug to a placebo (a pill with no active medicine) to see if it helps prevent relapse.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07410676RecruitingPhase 1/Phase 2
Donor NK cells with IL-15 and pembrolizumab for advanced solid tumors
This trial tests a new type of cell therapy (natural killer cells) made from a donor, combined with low-dose IL-15 (a protein that helps these cells work) and sometimes with pembrolizumab (Keytruda), for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this combination can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges Any age - NCT07415564Recruiting
Support program for advanced cancer patients and their caregivers
This trial offers coaching and symptom management support for people with advanced breast, GI, or melanoma cancer and their caregivers. The goal is to improve quality of life for both.
Tucson, ArizonaAges 18 years+ - NCT07415499Recruiting
Breast density impact on mammography screening
This study looks at how breast density affects the ability of mammograms to find breast cancer. It involves women who had a mammogram through a specific screening program.
Verduno, Italy/CNAges 45–75 - NCT07411443Recruiting
AI breast cancer screening study for women
This study tests whether artificial intelligence (AI) can improve breast cancer screening in women. It may help find cancer earlier and more accurately.
Shanghai, ShaghaiAges 35–69 - NCT07410494RecruitingPhase 1/Phase 2
Personalized donor cell therapy for advanced solid tumors
This trial tests a personalized cell therapy (CAR-NK) using donor immune cells that are engineered to find and attack one or two markers on advanced solid tumors. It may be an option for people whose tumors have these specific markers and have exhausted other treatments.
Beijing, Beijing MunicipalityAges 8–85 - NCT07407439Recruiting
Real-world study of CDK4/6 inhibitors in advanced breast cancer
This study looks at how well CDK4/6 inhibitors (a type of targeted therapy) work in real-world patients with HR+/HER2- advanced breast cancer. By collecting medical data from people treated at this hospital, doctors hope to learn more about the effectiveness and safety of these drugs in everyday practice.
TianjinAges 18 years+ - NCT06823414Recruiting
Robotic-assisted nipple-sparing mastectomy trial
This trial tests a robotic-assisted surgery technique for women who need a mastectomy but can keep their skin and nipple. It aims to improve outcomes for breast cancer patients and those at high risk.
A Coruña, GaliciaAges 18 years+ - NCT06818370Recruiting
Coconut oil for preventing hair loss during chemo
This trial tests whether applying coconut oil to the scalp can reduce hair loss caused by a common breast cancer chemotherapy combination (doxorubicin and cyclophosphamide). It may help women who are about to start this specific chemo regimen.
Ankara, YenimahalleAges 18–65 - NCT06024187Recruiting
Cold vs. heat cutting in nipple-sparing mastectomy
This study compares two ways of cutting tissue during nipple-sparing mastectomy (breast removal with nipple preservation) followed by immediate implant reconstruction. One method uses a cold instrument, the other uses heat (electrocautery). The goal is to see which leads to better nipple survival and healing.
Guangzhou, GuangdongAges 18–75 - NCT06495632RecruitingPhase 4
Scheduled or as-needed pain medicine after surgery?
This study compares taking pain medicine on a fixed schedule versus only when you need it after common outpatient surgeries. It aims to find which approach works better for controlling pain and reducing side effects.
Fayetteville, North CarolinaAges 18–65 - NCT07400926Recruiting
Study of a new inserter for a glaucoma implant
This trial is testing a new way to deliver a medication (travoprost) directly into the eye using a small implant. It's for people with open-angle glaucoma and aims to see how well the updated inserter works.
Kenosha, WisconsinAges 18 years+ - NCT07399080Enrolling by invitation
Study of a drug-coated balloon for leg artery disease
This trial is testing a special balloon coated with a drug (paclitaxel) to treat narrowed or blocked arteries in the leg. It aims to see how well this balloon works to keep the artery open.
SeoulAges 19–85 - NCT07401381RecruitingPhase 1
Injectable vs. oral letrozole in early breast cancer
This study compares a new injectable form of the drug letrozole with the standard oral pill. It aims to find out if the injection works as well as the pill for women who have already taken letrozole for their early breast cancer and have finished their initial treatment.
Beverly Hills, CaliforniaAges 18–80 - NCT07405801RecruitingPhase 2
Inavolisib plus ribociclib plus fulvestrant for advanced breast cancer
This trial tests a combination of three drugs (inavolisib, ribociclib, and fulvestrant) compared to a placebo plus two of the drugs (ribociclib and fulvestrant) for people with advanced hormone receptor-positive breast cancer who have not had prior treatment for advanced disease. The goal is to see if adding inavolisib improves outcomes.
Anaheim, CaliforniaAges 18 years+
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,615 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.